An increasing number of studies reported that ADAM17 was overexpression in tumors, including the esophageal squamous cell carcinoma, stomach cancer, breast cancer, prostate cancer, colorectal cancer, and others. The gene discussed is ADAM17; the disease is gastric neoplasm.